These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6973945)

  • 41. Platelet membrane glycoproteins implicated in ristocetin-induced aggregation. Studies of the proteins on platelets from patients with Bernard-Soulier syndrome and von Willebrand's disease.
    Jenkins CS; Phillips DR; Clemetson KJ; Meyer D; Larrieu MJ; Lüscher EF
    J Clin Invest; 1976 Jan; 57(1):112-24. PubMed ID: 1081991
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of ristocetin-Willebrand factor assay and ristocetin-induced platelet aggregation.
    Olson JD; Brockway WJ; Fass DN; Magnuson MA; Bowie EJ
    Am J Clin Pathol; 1975 Feb; 63(2):210-8. PubMed ID: 1078748
    [TBL] [Abstract][Full Text] [Related]  

  • 43. von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease.
    Miller JL; Kupinski JM; Castella A; Ruggeri ZM
    J Clin Invest; 1983 Nov; 72(5):1532-42. PubMed ID: 6415113
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Agglutination of platelet-type von Willebrand's disease platelets by bovine von Willebrand factor.
    Takahashi H; Shibata A
    Thromb Haemost; 1985 Apr; 53(2):204-7. PubMed ID: 2992113
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Studies on the effects of five monoclonal antibodies, polyclonal rabbit antibody and homologous antibody to human F VIII/vWF on ristocetin-induced platelet agglutination and platelet retention by glass bead column].
    Ogata K; Minami S; Kamiya T
    Rinsho Ketsueki; 1985 Jul; 26(7):1042-9. PubMed ID: 2414486
    [No Abstract]   [Full Text] [Related]  

  • 46. Interaction of platelets, von Willebrand factor, and ristocetin during platelet agglutination.
    Moake JL; Olson JD; Troll JH; Weinger RS; Peterson DM; Cimo PL
    J Lab Clin Med; 1980 Jul; 96(1):168-84. PubMed ID: 6967100
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of platelet activation on the agglutination of platelets by von Willebrand factor.
    Mills DC; Hunchak K; Karl DW; Kirby EP
    Mol Pharmacol; 1990 Feb; 37(2):271-7. PubMed ID: 2154674
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ristocetin and von Willebrand factor analysis.
    Light J; Williams CE; Entwistle MB
    Med Lab Sci; 1987 Jul; 44(3):272-9. PubMed ID: 3501515
    [No Abstract]   [Full Text] [Related]  

  • 49. A simplified assay for von Willebrand factor.
    Rivard GE; Daviault MB
    Thromb Res; 1978 Apr; 12(4):677-80. PubMed ID: 307285
    [No Abstract]   [Full Text] [Related]  

  • 50. [Determination of the von Willebrand factor].
    Turek P; Sikorová J; Vorlová Z
    Vnitr Lek; 1984 Jun; 30(6):550-6. PubMed ID: 6332414
    [No Abstract]   [Full Text] [Related]  

  • 51. Interaction of porcine von Willebrand factor (platelet aggregating factor) with human platelets.
    Finlay TH; Marcus DL; Kowalski S; Silber P
    Biochim Biophys Acta; 1981 Jan; 672(1):79-88. PubMed ID: 6260227
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interaction of the cysteine-rich domain of snake venom metalloproteinases with the A1 domain of von Willebrand factor promotes site-specific proteolysis of von Willebrand factor and inhibition of von Willebrand factor-mediated platelet aggregation.
    Serrano SMT; Wang D; Shannon JD; Pinto AFM; Polanowska-Grabowska RK; Fox JW
    FEBS J; 2007 Jul; 274(14):3611-3621. PubMed ID: 17578514
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of von Willebrand factor-induced platelet agglutination by ADP does not result from reduced binding of total von Willebrand factor or its larger multimers.
    Zucker MB; Puszkin EG; Sussman II; Mauss EA
    J Lab Clin Med; 1990 Sep; 116(3):305-14. PubMed ID: 2401846
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Whole blood ristocetin-activated platelet impedance aggregometry (Multiplate) for the rapid detection of Von Willebrand disease.
    Schmidt DE; Bruzelius M; Majeed A; Odeberg J; Holmström M; Ågren A
    Thromb Haemost; 2017 Jul; 117(8):1528-1533. PubMed ID: 28692107
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A human myeloma-produced monoclonal protein directed against the active subpopulation of von Willebrand factor.
    Bovill EG; Ershler WB; Golden EA; Tindle BH; Edson JR
    Am J Clin Pathol; 1986 Jan; 85(1):115-23. PubMed ID: 3079626
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A rapid, automated VWF ristocetin cofactor activity assay improves reliability in the diagnosis of Von Willebrand disease.
    Bowyer AE; Shepherd F; Kitchen S; Makris M
    Thromb Res; 2011 Apr; 127(4):341-4. PubMed ID: 21186048
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Simple rapid test for assaying ristocetin cofactor].
    Aznar JA; Borrego D; Martín G; Jorquera J; Jiménez C; García I; Marty ML
    Sangre (Barc); 1982; 27(5):959-66. PubMed ID: 6984787
    [No Abstract]   [Full Text] [Related]  

  • 58. Inverse relationship between ristocetin co-factor levels and platelet aggregation in insulin dependent diabetes.
    Porta M; McCraw A; Kohner EM
    Thromb Res; 1982 Mar; 25(6):507-12. PubMed ID: 6981229
    [No Abstract]   [Full Text] [Related]  

  • 59. [Von Willebrand factor. Its role in hemostasis and the method of its determination].
    Baluda VP; Sushkevich GN
    Lab Delo; 1976; (8):451-5. PubMed ID: 66393
    [No Abstract]   [Full Text] [Related]  

  • 60. Inhibition of ristocetin-induced platelet agglutination by vancomycin.
    Moake JL; Cimo PL; Peterson DM; Roper P; Natelson EA
    Blood; 1977 Sep; 50(3):397-406. PubMed ID: 301760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.